BRPI0619759A2 - dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas - Google Patents

dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas Download PDF

Info

Publication number
BRPI0619759A2
BRPI0619759A2 BRPI0619759-0A BRPI0619759A BRPI0619759A2 BR PI0619759 A2 BRPI0619759 A2 BR PI0619759A2 BR PI0619759 A BRPI0619759 A BR PI0619759A BR PI0619759 A2 BRPI0619759 A2 BR PI0619759A2
Authority
BR
Brazil
Prior art keywords
formula
substituted
unsubstituted
compound according
mmol
Prior art date
Application number
BRPI0619759-0A
Other languages
English (en)
Portuguese (pt)
Inventor
H. Posner Gary
Paik Ikhyeon
Borstnik Kristina
Chang Wonsuk
Sinishtaj Sandra
Anthony Maio William
Gaetano D'angelo John
Elaine Woodard Lauren
Soloman Kalinda Alvin
R. Usera Aimee
Catherine Hess Lindsey
Scott Rosenthal Andrew
Oh Seongho
C. Baege Astrid
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of BRPI0619759A2 publication Critical patent/BRPI0619759A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0619759-0A 2005-12-08 2006-11-17 dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas BRPI0619759A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US74854805P 2005-12-08 2005-12-08
US60/748,548 2005-12-08
US76512506P 2006-02-03 2006-02-03
US60/765,125 2006-02-03
US79481106P 2006-04-25 2006-04-25
US60/794,811 2006-04-25
PCT/US2006/044845 WO2007067333A2 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Publications (1)

Publication Number Publication Date
BRPI0619759A2 true BRPI0619759A2 (pt) 2011-10-18

Family

ID=38123365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619759-0A BRPI0619759A2 (pt) 2005-12-08 2006-11-17 dìmeros de trioxano tendo atividades antimalária de longa duração e anticáncer elevadas

Country Status (10)

Country Link
US (1) US20090291923A1 (enExample)
EP (1) EP1962596A4 (enExample)
JP (1) JP2009518397A (enExample)
KR (1) KR20080081310A (enExample)
AU (1) AU2006323040A1 (enExample)
BR (1) BRPI0619759A2 (enExample)
CA (1) CA2632200A1 (enExample)
IL (1) IL191597A0 (enExample)
MX (1) MX2008007358A (enExample)
WO (1) WO2007067333A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
US8592611B2 (en) 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010032165A2 (en) * 2008-09-19 2010-03-25 North-West University Prodrugs of artemisinin
US8884032B2 (en) 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
IN2012DN05028A (enExample) 2009-12-07 2015-10-23 Univ Johns Hopkins
CA2782110A1 (en) * 2009-12-07 2011-06-16 Johns Hopkins University N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
US9493480B2 (en) 2011-04-15 2016-11-15 The Johns Hopkins University Monomeric trioxane amide sulfur compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121749A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev 2,3-dioxabicycloÚ3.3.1¾nonane derivatives and antimalarial pharmaceutical compositions comprising them
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US20050240034A1 (en) * 2002-05-07 2005-10-27 Mitchell Avery Artemisinin-based peroxide compounds as broad spectrum anti-infective agents
US7417156B2 (en) * 2002-09-27 2008-08-26 Johns Hopkins University Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers

Also Published As

Publication number Publication date
EP1962596A2 (en) 2008-09-03
WO2007067333A3 (en) 2008-01-31
KR20080081310A (ko) 2008-09-09
JP2009518397A (ja) 2009-05-07
US20090291923A1 (en) 2009-11-26
EP1962596A4 (en) 2010-09-22
CA2632200A1 (en) 2007-06-14
AU2006323040A1 (en) 2007-06-14
WO2007067333A2 (en) 2007-06-14
IL191597A0 (en) 2009-02-11
MX2008007358A (es) 2008-11-10

Similar Documents

Publication Publication Date Title
JP7850663B2 (ja) スピロ環含有キナゾリン化合物
US11459327B1 (en) Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof
AU2018203354B2 (en) Hepatitis B antiviral agents
EP4092026A1 (en) Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereof
ES2834065T3 (es) Inhibidores de arginasa y sus aplicaciones terapéuticas
TW202341983A (zh) 用於降解突變kras蛋白之化合物及其應用
CA3146679A1 (en) Adenosine derivative and pharmaceutical composition comprising the same
UA121271C2 (uk) Заміщені 3-азабіцикло[3.1.0]гексани як інгібітори кетогексокінази
EA019749B1 (ru) Противовирусные соединения
AU2018291688B2 (en) Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections
IL305009A (en) A prodrug compound, a method for its preparation and its use
US20250195475A1 (en) Cdk2 inhibitor and preparation method and use thereof
EP4238965A1 (en) 14-chloro-beta-elemene nitric oxide donor type derivative, preparation and application thereof
CN114591201B (zh) 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用
CA3082499A1 (en) Quinazolinone compound and application thereof
TW201625313A (zh) 新穎麩胺酸衍生物及其用途
JP2021532107A (ja) ジカチオン化合物及びその製造方法と使用
AU2021328979B2 (en) Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof
JP2018536619A (ja) トリプトリドのc14ヒドロキシルエステル化アミノ酸誘導体、ならびにその製造方法および使用
US20090291923A1 (en) Trioxane dimers having high anticancer and long-lasting antimalarial activities
CA3092544A1 (en) 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
EP2358198A1 (en) Hydroxyethylamino sulfonamide derivatives
CA3049428A1 (en) Small molecule inhibitors of neutral sphingomyelinase 2 (nsmase2) for the treatment of neurodegenerative diseases
CN101325874A (zh) 具有高抗癌活性和长效抗疟活性的三噁烷二聚物
EP3699184A1 (en) Triptolide derivative and preparation method therefor and use thereof

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]